Antitumor efficacy of triple monoclonal antibody inhibition of epidermal growth factor receptor (EGFR) with MM151 in EGFR-dependent and in cetuximab-resistant human colorectal cancer cells

Lignende værker

• Therapeutic value of EGFR inhibition in CRC and NSCLC: 15 years of clinical evidence
  af: Troiani, Teresa, et al.
  Udgivet: (2016)
• Therapeutic efficacy of SYM004, a mixture of two anti-EGFR antibodies in human colorectal cancer with acquired resistance to cetuximab and MET activation
  af: Napolitano, Stefania, et al.
  Udgivet: (2017)
• Mechanisms of resistance to EGFR-targeted drugs: lung cancer
  af: Morgillo, Floriana, et al.
  Udgivet: (2016)
• Efficacy of continuous EGFR-inhibition and role of Hedgehog in EGFR acquired resistance in human lung cancer cells with activating mutation of EGFR
  af: Della Corte, Carminia Maria, et al.
  Udgivet: (2017)
• Receptor tyrosine kinase-dependent PI3K activation is an escape mechanism to vertical suppression of the EGFR/RAS/MAPK pathway in KRAS-mutated human colorectal cancer cell lines
  af: Vitiello, Pietro Paolo, et al.
  Udgivet: (2019)